We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.6%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$758B
AUM Growth
+$77.4B
Cap. Flow
+$26.3B
Cap. Flow %
3.47%
Top 10 Hldgs %
14.89%
Holding
8,036
New
455
Increased
4,497
Reduced
2,118
Closed
221

Top Buys

Rank Stock Value
1
BND icon
Vanguard Total Bond Market
BND
+$1.49B
2
NET icon
Cloudflare
NET
+$1.3B
3
RBLX icon
Roblox
RBLX
+$1.1B
4
W icon
Wayfair
W
+$1.05B
5
MSFT icon
Microsoft
MSFT
+$708M

Sector Composition

Rank Sector Weight
1 Technology 20.18%
2 Healthcare 9.88%
3 Consumer Discretionary 9.14%
4 Communication Services 9.1%
5 Financials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGS icon
5501
GeneDx Holdings
WGS
$2.32B
$414K ﹤0.01%
895
-1,754
-66% -$753K
SCHK icon
5502
Schwab 1000 Index ETF
SCHK
$5.98B
$413K ﹤0.01%
19,354
+2,624
+16% +$54.4K
TTNP
5503
DELISTED
Titan Pharmaceuticals
TTNP
$413K ﹤0.01%
7,940
+7,939
+793,900% +$397K
IAF
5504
abrdn Australia Equity Fund
IAF
$126M
$411K ﹤0.01%
21,207
+5,422
+34% +$103K
DSKE
5505
DELISTED
Daseke, Inc. Common Stock
DSKE
$411K ﹤0.01%
63,564
-138,124
-68% -$1M
RBNC
5506
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$411K ﹤0.01%
14,810
+6,227
+73% +$179K
REV
5507
DELISTED
Revlon, Inc.
REV
$411K ﹤0.01%
31,975
-29,531
-48% -$371K
ACRS icon
5508
Aclaris Therapeutics
ACRS
$833M
$410K ﹤0.01%
23,339
+14,465
+163% +$329K
FOA icon
5509
Finance of America Companies
FOA
$204M
$410K ﹤0.01%
+5,370
New +$520K
MVBF icon
5510
MVB Financial
MVBF
$401M
$410K ﹤0.01%
9,616
+4,486
+87% +$183K
PFIG icon
5511
Invesco Fundamental Investment Grade Corporate Bond ETF
PFIG
$118M
$408K ﹤0.01%
15,136
-872
-5% -$23.4K
SPRY icon
5512
ARS Pharmaceuticals
SPRY
$555M
$408K ﹤0.01%
+13,224
New +$424K
VIRX
5513
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$407K ﹤0.01%
35,946
-4,648
-11% -$46.6K
CMU
5514
DELISTED
MFS High Yield Municipal Trust
CMU
$406K ﹤0.01%
85,528
-5,859
-6% -$27.4K
PKBK icon
5515
Parke Bancorp
PKBK
$416M
$406K ﹤0.01%
20,751
+3,539
+21% +$72.2K
RGLS
5516
DELISTED
Regulus Therapeutics
RGLS
$406K ﹤0.01%
49,963
+33,638
+206% +$375K
ASMB icon
5517
Assembly Biosciences
ASMB
$624M
$405K ﹤0.01%
8,700
+7,970
+1,092% +$395K
ESSA
5518
DELISTED
ESSA Bancorp
ESSA
$405K ﹤0.01%
24,683
+2,266
+10% +$36K
HURC icon
5519
Hurco Companies Inc
HURC
$144M
$404K ﹤0.01%
11,528
+2,064
+22% +$71.8K
MRCC
5520
DELISTED
Monroe Capital Corp
MRCC
$404K ﹤0.01%
37,637
+1,477
+4% +$16K
AXAS
5521
DELISTED
Abraxas Petroleum Corp
AXAS
$403K ﹤0.01%
124,904
+94,335
+309% +$249K
PZN
5522
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$402K ﹤0.01%
36,581
-12,649
-26% -$140K
NATH icon
5523
Nathan's Famous
NATH
$397M
$401K ﹤0.01%
5,618
-3,713
-40% -$248K
BRCN
5524
DELISTED
Burcon NutraScience Corporation
BRCN
$400K ﹤0.01%
+143,477
New +$459K
HZN
5525
DELISTED
Horizon Global Corporation
HZN
$399K ﹤0.01%
47,059
+19,644
+72% +$171K

Similar funds

Morgan Stanley's Q2 2021 Portfolio in Review

As of Q2 2021, Morgan Stanley held 8,036 positions worth $758B, up 11% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley deployed $26.3B of net new capital in Q2 2021, opening 455 new positions and adding to 4,497 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.83B trimmed.

  • Morgan Stanley's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
  • Morgan Stanley added most to Vanguard Total Bond Market in Q2 2021, an estimated $1.49B increase.
  • Morgan Stanley's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.83B.
  • Morgan Stanley fully exited RealPage, Inc. in Q2 2021, selling an estimated $193M.
  • Morgan Stanley's ten largest holdings make up 15% of its $758B portfolio in Q2 2021.
  • Morgan Stanley opened 455 new positions and closed 221 in Q2 2021.
  • Morgan Stanley's portfolio value rose 11% quarter-over-quarter to $758B.

Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.